NSC-55929 |
E-GLADES |
ERYC |
PAEDIATHROCIN |
ERYGEL |
E-SOLVE 2 |
E-MYCIN |
ERYDERM |
A/T/S |
C-SOLVE-2 |
J01FA01 |
OFTALMOLOSA CUSI ERITROMICINA |
WYAMYCIN |
STIEMYCIN |
ERYTHROCIN |
KERYMAX |
ZINERYT |
SANSAC |
AKNEMYCIN PLUS |
ERYACNE 2 |
ERYMAX |
STATICIN |
EMGEL |
ERYACNE 4 |
R-P MYCIN |
AKNE-MYCIN |
ERY-TAB |
BRISTAMYCIN |
ROMMIX 250 EC |
ROBIMYCIN |
ERYTHRO 200 |
ERYPAR |
ERYC 125 |
ERYC SPRINKLES |
ERYTHROMYCIN |
ERYCETTE |
ERYTHRO-STATIN |
TILORYTH |
ERYTHRA-DERM |
ILOTYCIN |
PCE |
GALLIMYCIN |
T-STAT |
ROMMIX 500 EC |
ERYMAX SPRINKLE |
RETCIN |
E-BASE |
PFIZER-E |
BENZAMYCIN |
ISOTREXIN |
ÉRYTHROMYCINE |
(2R,4S,5R,8R,12R,14R)-11-[(3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYL-OXAN-2-YL]OXY-5-ETHYL-3,4,12-TRIHYDROXY-9-[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYL-OXAN-2-YL]OXY-2,4,8,10,12,14-HEXAMETHYL-6-OXACYCLOTETRADECANE-1,7-DIONE |
6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-14-ETHYL-7,12,13-TRIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-3,5,7,9,11,13-HEXAMETHYL-OXACYCLOTETRADECANE-2,10-DIONE(ERYTHROMYCIN) |
ERYTHROMYCIN A |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY)-14-ETHYL-7,12,13-TRIHYDROXY-4-(5-HYDROXY-4-METHOXY-4,6-DIMETHYL-TETRAHYDRO-PYRAN-2-YLOXY)-3,5,7,9,11,13-HEXAMETHYL-OXACYCLOTETRADECANE-2,10-DIONE |
ERYTHROMYCINUM |
ERITROMICINA |
ERYTHROMYCIN C |
ABOMACETIN |
ERTHROMYCIN |
3''-O-DEMETHYLERYTHROMYCIN |
(2R,4S,5R,8R,12R,14R)-11-[(3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2-YL]OXY-5-ETHYL-3,4,12-TRIHYDROXY-9-[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLOXAN-2-YL]OXY-2,4,8,10,12,14-HEXAMETHYL-6-OXACYCLOTETRADECANE-1,7-DIONE |
ERYTHROMYCINE |
rxcui:4053 |
chemidplus:114-07-8 |
drugbank:00199 |
chembl:CHEMBL532 |
pubchem.compound:12560 |
n/a |
Combination therapy | Erythromycin,Sulfisoxazole |
CHEMBL532 | ChEMBL Drug ID |
C476 | NCI drug code |
D02YIZ | TTD Drug ID |